Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00949234 · ClinicalTrials.gov registry record · Phase 2
Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV
A Phase 2 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 2
- Development phase
- 267
- Enrollment target
NCT00949234: Completed Phase 2 study, sponsored by University of California, Los Angeles.
NCT00949234 is a Phase 2 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 267 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (101% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00949234, a Phase 2 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 267 participants
- Enrollment target
Study Summary
The purpose of this program is to evaluate an effort to provide a comprehensive package of HIV prevention services of which post-exposure prophylaxis (medicines that may help prevent HIV infection after an exposure) can be a part. It will also include risk reduction information and testing for other sexually transmitted infections.
Interventions
- DRUG tenofovir + emtricitabine, lopinavir/ritonavir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 267 participants |
| Start Date | 2010-03 |
| Est. Completion | 2011-08 |
| Phase | Phase 2 |
What the finished NCT00949234 record still lists
NCT00949234 is an interventional study that assigns participants to a tested intervention. The registered 267 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (101% higher).
The record links to 0 conditions, and to 1 intervention - of which tenofovir + emtricitabine, lopinavir/ritonavir is the first listed.
NCT00949234 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00949234 about?
NCT00949234 is a clinical study titled "Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV". The purpose of this program is to evaluate an effort to provide a comprehensive package of HIV prevention services of which post-exposure prophylaxis (medicines that may help prevent HIV infection after an exposure) can be a part. It will also include risk reduction information and testing for other...
What is the current status of trial NCT00949234?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 267 participants. The study started on 2010-03. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00949234?
The interventions under investigation include: tenofovir + emtricitabine, lopinavir/ritonavir (DRUG).
Who is sponsoring clinical trial NCT00949234?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00949234's enrollment target sits among peer trials
267 209th of 2000 higher than 1,792 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04997109 · 267 participants · NA
Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy
- NCT05355701 · 267 participants · Phase 1
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
- NCT06203509 · 267 participants · NA
Improving Care Transitions for Medicaid Insured Individuals With Co-occurring Serious Mental Illness
- NCT05000632 · 268 participants · NA
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia